Home > Newborn Disorders > Homocystinuria
Homocystinuria
Names
Homocystinuria
Classic homocystinuria
Homocystinemia
Cystathionine beta-synthase deficiency (CBS)
Overview
A deficiency of cystathionine beta-synthase (CBS) results in the inability to degrade homocystine to cystathionine, resulting in increased levels of homocysteine and methionine. A variant that represents a minority of cases is responsive to vitamin B6 (pyridoxine), but this type may be missed by newborn screening. Elevated homocysteine impairs the function of several proteins (including fibrillin) interfering with the formation of disulfide bonds and impairs endothelial function, leading to thrombosis.Prevalence
about 1/200,000 - 1/300,000 live births [Homocystinuria info for professionals (STAR-G)]; as high as 1:65,000 in Ireland [Homocystinuria (GeneReviews)]Clinical Characteristics
With treatment normal IQ is possible and reduction of thromboembolic events may decrease the incidence of other sequelae, such as ectopia lentis, seizures, and psychiatric problems. Without treatment, symptoms vary widely and may present at different ages, ranging from lens dislocation, poor vision, developmental delays, marfanoid habitus, and acute thromboembolism.Initial symptoms in infants and toddlers may include:
- developmental delay;
- emotional and behavior problems;
- thromboembolism; and
- ectopia lentis (dislocation of the ocular lens) or severe myopia (nearsightedness).
Findings in older children and adults may include:
- Marfanoid habitus: tall/ thin build; long fingers, arms, and legs
- genu valgum, pes cavus
- osteoporosis
- malar flush
- decreased hair, skin, iris pigmentation
- seizures
- vascular disease and stroke
- psychiatric abnormalities
- mental retardation
Follow-up on positive screening test
Quantitative plasma amino acid analysis, total plasma homocysteine.Primary care management
Upon notification of the + screen
- Contact the family and evaluate the infant for poor feeding or other problems
- Urgent treatment is not likely to be needed in the newborn period, but patients should be referred immediately (see the ACT Sheet for Homocystinuria (ACMG)
(
347 KB)
for additional information)
- To confirm the diagnosis, work with the following service(s): Utah Newborn Screening Program, (801-584-8256); See also Services below
- For evaluation and ongoing collaborative management, consult the following service(s): Medical Genetics, (801-231-3599); See also Services below
If the diagnosis is confirmed
- Educate the family regarding signs, symptoms, and the need for urgent care when the infant becomes ill (see Homocystinuria info for parents (STAR-G))
- Assist in implementation and maintenance of a diet low in methionine and proteins; baby aspirin is also recommended starting in late teenager years
- Provision of vitamin B6, betaine, vitamin B12, and methylfolate may be indicated
- Regular blood and urine tests to monitor amino acid levels and diet may be indicated
- For those identified after irreversible consequences, assist in management, particularly with developmental and educational interventions
Specialty Care Collaboration
Initial consultation and ongoing collaboration if the child is affected. A dietician may work with the family to devise an optimal approach to dietary management.Resources
Information & Support
For Professionals
Homocystinuria info for professionals (STAR-G)
From the Screening, Technology and Research in Genetics (STAR-G) program, one of a series of Disorder Fact Sheets for Professionals;
structured list of information about the condition, with links to more information.
ACT Sheet for Homocystinuria (ACMG)
(
347 KB)
Developed by the American College of Medical Genetics (ACMG), includes recommended responses to positive newborn screening
test results, diagnostic evaluation, clinical expectations, and sources of additional information. See the ACMG ACT Sheets
and Confirmatory Algorithms (link elsewhere on this page) for more info and sheets on other conditions.
ACT Sheets and Confirmatory Algorithms (ACMG)
The American College of Medical Genetics (ACMG) has developed ACTion (ACT) Sheets and algorithms for responding to positive
newborn screening test results. This page contains a table with links to all of the ACT Sheets and related algorithms.
Homocystinuria (GeneReviews)
Excellent review by Jonathan D. Picker, MBChB, PhD and Harvey L. Levy, MD including clinical description, differential, management,
genetic counseling, molecular genetics, and a bibliography.
Resources for homocystinuria (NLM)
Comprehensive compilation of links to information, articles, research, case studies, genetics, and more; from the National
Library of Medicine and the Genetic Alliance.
Homocystinuria (OMIM)
Extensive review of the literature, including clinical features and genetics, from the Online Mendelian Inheritance in Man
site, hosted by Johns Hopkins University, providing technical information for providers on genetic disorders, links to MEDLINE,
and links to other scientific information and sites.
Utah Newborn Screening Program
The site provides information and statistics about the program and related legislation, training for practices, and the conditions
screened for.
For Parents and Patients
Homocystinuria info for parents (STAR-G)
From the Screening, Technology and Research in Genetics (STAR-G) program, providing information for parents about homocystinuria
and links to other sites including parent support groups.
Homocystinuria (Genetics Home Reference)
Excellent, detailed review aimed at patients and families from the National Library of Medicine's Genetics Home Reference
site.
Services
Newborn Screening Programs
Utah Newborn Screening Program,
more info...
44 Mario Capecchi Drive
Salt Lake City, UT 84114
Phone: 801-584-8256
Fax: 801-536-0966
http://health.utah.gov/newbornscreening
Pediatric Medical Genetics
See all Pediatric Medical Genetics services providers (3) in our database.
For other services related to this condition, browse our Services categories or search our database.
Helpful Articles
PubMed search for articles on homocystinuria in the last 5 years.
Mudd SH.
Hypermethioninemias of genetic and non-genetic origin: A review.
Am J Med Genet C Semin Med Genet.
2011;157(1):3-32.
PubMed abstract
This review covers briefly the major conditions, genetic and non-genetic, sometimes leading to abnormally elevated methionine,
with emphasis on recent developments. A major aim is to assist in the differential diagnosis of hypermethioninemia.
Authors
| Reviewing Author: | Nicola Longo MD, PhD, 3/2011 |
| Compiled and edited by: | Alfred Romeo RN, PhD, 3/2007 |
| Content Last Updated: | 4/2011 |
